[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100539675":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":33,"responsibleParty":54,"collaborators":10,"id":56,"slug":57,"hasResults":58,"nctId":59,"briefTitle":60,"officialTitle":60,"acronym":10,"eligibilityCriteria":61,"healthyVolunteers":58,"sex":62,"minAge":63,"maxAge":10,"enrollmentInfo":64,"targetDuration":10,"studyType":67,"phases":10,"briefSummary":68,"conditions":69,"keywords":72,"overallStatus":36,"whyStopped":10,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"UNC Lineberger Comprehensive Cancer Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Palliative radiation therapy",null,"Subjects who are with metastatic cancer receive palliative radiation therapy.",[13],"Radiation: Radiation therapy",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"RADIATION","Radiation therapy","Subjects with metastatic cancer receive radiation therapy.",[9],[21],{"name":22,"affiliation":5,"role":23},"Shivani Sud, MD","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":10,"email":29},"Kadiata Toumbou","CONTACT","(202) 569-3721","kadiata@email.unc.edu",{"name":31,"role":27,"phone":10,"phoneExt":10,"email":32},"Victoria Xu","victoria_xu@med.unc.edu",[34],{"facility":35,"status":36,"city":37,"state":38,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill","RECRUITING","Chapel Hill","North Carolina","27599","United States","US",{"type":43,"coordinates":44},"Point",[45,46],-79.05584,35.9132,{"lat":46,"lon":45},[49,53],{"name":50,"role":27,"phone":51,"phoneExt":10,"email":52},"Shivani Sud, MS","919-918-5924","sshivani.sud@unchealth.unc.edu",{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100539675","unc-metastatic-cancer-radiation-therapy-registry-100539675",false,"NCT06306924","UNC Metastatic Cancer Radiation Therapy Registry","Inclusion Criteria:\n\nWritten informed consent was obtained to participate in the study and HIPAA\n\nAuthorization for release of personal health information. Ability to understand and willingness to sign informed consent\n\nDiagnosed with or is suspected to have metastatic cancer.\n\nAge ≥ 18 years at the time of consent.\n\nEvaluated to receive radiation therapy as part of their standard-of-care treatment plan.\n\nExclusion Criteria:\n\nAll participants must not meet any of the following exclusion criteria prior to enrollment to participate in this study:\n\nAny serious medical or psychiatric disorder that would interfere with the participant's ability to give informed consent.","ALL","18 Years",{"count":65,"type":66},2000,"ESTIMATED","OBSERVATIONAL","The purpose of this registry is to collect clinical data from participants attending UNC Hospitals who present with metastatic cancer and are evaluated to receive radiation therapy as part of their standard of care treatment. The goal of this study is to provide a foundation for studies designed to identify projects across the translational continuum related to metastatic cancer and radiation therapy treatment. The relevant clinical data will be linked to patient-reported outcomes (PROs) thus allowing for a unique and robust dataset. Ultimately, this registry will provide current and future studies with the ability to analyze the correlation of radiation therapy regimens with metastatic cancer outcomes.",[70,71],"Cancer","Metastatic Cancer",[73],"radiation therapy","2026-04-30",{"date":76,"type":77},"2026-05-06","ACTUAL",{"date":79,"type":77},"2024-04-21",{"date":81,"type":66},"2033-05",{"name":5,"class":6},1]